Scale your production, drive innovation, and thrive in an emerging hub for pharmaceutical research and manufacturing.
Home > Sectors > Life Sciences > Pharmaceuticals
The Edmonton Region is home to well-established infrastructure, and world-class research centres including the University of Alberta’s Drug Development and Innovation Centre and Li Ka Shing Institute for Virology. With top-tier universities and colleges, the Edmonton Region produces a steady pipeline of qualified professionals including a high concentration of Ph.D. graduates and researchers that are driving the growth of pharmaceutical research and manufacturing enterprises in the Region.
To top it off, with the lowest cost of lab space in Canada, attractive tax incentives, and a streamlined regulatory pathway, the Edmonton Region offers a cost-competitive environment to scale your operations.
The Edmonton Region is well-positioned to be a Canadian hub for pharmaceutical R&D and manufacturing. The Region is home to a strong ecosystem that supports innovation and has the expertise to bring new medical breakthroughs through to commercialization.
Since 2015, the Alberta Machine Intelligence Institute (Amii) has been collaborating with Alberta Health Services, Canada’s largest single healthcare system, to integrate AI in both hospital and research settings.
Access a specialized workforce with expertise in pharmaceutical production and leverage state-of-the-art facilities.
Reduced operating costs with Alberta's low corporate tax rate of 8%, affordable lab space, office rates, and talent.
Benefit from efficient regulatory processes, government incentives, and a collaborative network of industry experts.
Discover pharmaceutical companies that already call the Edmonton Region home.
API, a leading industry-funded, not-for-profit organization in Canada, is driving the nearly $200 million Canadian Critical Drug Initiative (CCDI) with the University of Alberta. This initiative is building a critical life sciences hub in Edmonton, focused on integrated research, commercialization, and manufacturing.
The Edmonton Region is home to Gilead’s largest operation in Canada. Gilead currently markets compounds to treat hepatitis C, HIV/AIDS, and cancer. In 2015, Gilead invested $100 million to upgrade their existing facility and add a manufacturing building and processing tower, expanding its operations significantly and more than doubling its team.
DrugBank is the world’s first and largest intelligent and comprehensive drug knowledge platform. With the help of artificial intelligence, DrugBank gathers, authors, verifies, and structures all of the latest biomedical information into one platform.
North American Free Trade Agreement or Canada-United States-Mexico
The Comprehensive Economic and Trade Agreement with the European Union
The Comprehensive an Progressive Agreement for Trans-Pacific Partnership
If you have any questions, require further information, or would like to book a consultation, please send us a message.
Senior Manager, Business Development, Life sciences
